UNSPSC 51102864: Neomycin/polymyxin b/prednisolone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP350. This VA Drug Class (OP350) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OPHTHALMIC.

UNSPSC 51102864 Neomycin/polymyxin b/prednisolone is a Commodity code that in practice captures a narrow slice of pharmaceutical procurement — the code's nominal scope names a specific ophthalmic antibiotic-corticosteroid combination, yet recent state and local solicitations tagged under it span a much broader set of health-related products and services, including naloxone, safe drug deactivation systems, generic multi-source pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription program capabilities. State and local issuing bodies soliciting under this code range from county health departments and city fire departments to state health agencies and multistate cooperative purchasing alliances. The recent opportunities show that the code is being applied to both product procurement (finished goods delivered in bulk with quarterly or as-needed scheduling) and market-intelligence RFIs that precede formal solicitations for pharmacy benefit and prescription-fulfillment infrastructure.

Geographic activity concentrates in Florida and Minnesota, with Texas conducting preliminary market research. Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, response due July 26, 2023 — a date that has already passed, indicating this opportunity is closed. The City of Tampa's Purchasing Department issued IFB 26P00145 on March 25, 2026, for medical and first aid supplies (169 line items including respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, and medical consumables) for the Tampa Fire Department Rescue Division, with a response deadline of March 13, 2026, and an estimated contract value of $700,000.00; the award was sheltered for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, with a same-day response deadline, signaling early-stage program development before formal competitive solicitation.